The Current Ratio as of November 2024 (TTM) for Salarius Pharmaceuticals, Inc. (SLRX) is 7.73

According to Salarius Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.73. This represents a change of 57.38% compared to the average of 4.91 of the last 4 quarters.

Salarius Pharmaceuticals, Inc. (SLRX) Historical Current Ratio (quarterly & annually)

How has SLRX Current Ratio performed in the past?

The mean historical Current Ratio of Salarius Pharmaceuticals, Inc. over the last ten years is 12.89. The current 7.73 Current Ratio has changed 5.89% with respect to the historical average. Over the past ten years (40 quarters), SLRX's Current Ratio was at its highest in in the March 2015 quarter at 78.72. The Current Ratio was at its lowest in in the September 2019 quarter at 1.11.

Salarius Pharmaceuticals, Inc. (SLRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Salarius Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Salarius Pharmaceuticals, Inc. (SLRX) Average Current Ratio

How has SLRX Current Ratio performed in the past?

The current Current Ratio of Salarius Pharmaceuticals, Inc. (SLRX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Salarius Pharmaceuticals, Inc. (SLRX) Current Ratio vs. Peers

How is SLRX’s Current Ratio compared to its peers?

Salarius Pharmaceuticals, Inc.’s Current Ratio is greater than Akari Therapeutics, Plc (0.29), greater than Axcella Health Inc. (1.21), less than Magenta Therapeutics, Inc. (14.64), greater than Histogen Inc. (4.05), greater than Timber Pharmaceuticals, Inc. (1.95), less than Artelo Biosciences, Inc. (14.58), greater than Nutriband Inc. (6.57), greater than Aileron Therapeutics, Inc. (3.30), greater than First Wave BioPharma, Inc. (1.21), greater than SAB Biotherapeutics, Inc. (3.69), greater than Vaccinex, Inc. (0.77), greater than GeoVax Labs, Inc. (4.17), greater than Corvus Pharmaceuticals, Inc. (0.92), greater than Mereo BioPharma Group plc (6.10), greater than Affimed N.V. (1.93), greater than Pieris Pharmaceuticals, Inc. (4.82), less than Artelo Biosciences, Inc. (14.58), greater than Fresh Tracks Therapeutics, Inc. (6.98),

Build a custom stock screener for Salarius Pharmaceuticals, Inc. (SLRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Salarius Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Salarius Pharmaceuticals, Inc. (SLRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Salarius Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.